Odds of pre-op opioid use up with age 31 to 40 years, tobacco use, illicit drug use, depression.
Only 44 of parents would definitely go to ER if their child had headache that didn't improve with medication.
Radiofrequency denervation, typically used to treat lumbar and cervical zygapophyseal joint pain, has shown efficacy in treating thoracic zygapophyseal joint pain.
American emergency medicine physicians have been taking measures to address the ongoing opioid crisis, which affects emergency departments throughout the country.
Investigators examined rates, predictors, and outcomes of neuroimaging in pediatric and adolescent patients who presented to the ED with a headache.
Surgeon General Jerome M. Adams, M.D., M.P.H., has urged more Americans to carry naloxone, an FDA-approved medication that can be delivered via nasal mist or injection and can temporarily suspend the effects of opioid overdose.
A panel discussion event held at the US Food and Drug Administration gathered patients with chronic pain and FDA officials, to reconcile concerns around prescriptions of opioid medications with the needs of these patient populations.
Heat-stable carbetocin non-inferior for preventing blood loss of 500 ml, use of other uterotonic agents
Commission makes 6 recommendations to meet 2030 goals for non-communicable diseases
Chronic low back pain (LBP) defined as persistent or fluctuating musculoskeletal pain of lower back and lumbar spine lasting >3 months.
In adults with sickle cell disease, higher daily opioid use may be associated with poorer health-related quality of life.
A study assessing the impact of upscheduling of hydrocodone combined medications on APRN practices in Oklahoma revealed significant barriers to effective pain management.
Researchers deployed a survey to individuals who had received treatment for opioid use disorder to assess their use of buprenorphine.
The phase 3 SUMMIT-07 trial assessed the safety, efficacy, and tolerability of a new mu-opioid receptor agonist analgesic in adults with moderate to severe chronic lower back pain.
Investigators assessed the potential for abuse associated with NKTR-181, a new mu-opioid receptor agonist analgesic.
A combination of naltrexone induction and psychoeducational counseling was found to facilitate transition from active opioid use and buprenorphine maintenance in individuals with opioid use disorder.
The budesonide extended-release formulation was found to be safe and well tolerated for the remission of ulcerative colitis, regardless of age or gender.
Pediatric exposure to buprenorphine can result in serious adverse outcomes, especially among children aged younger than 6 years.
The Company indicated that they will work towards an New Drug Application submission for the treatment in the second half of 2018.
Belief in a long recovery, many symptoms attributed to pain negatively tied to improvement
Minority of opioid overdose survivors receive MOUD; buprenorphine, MMT linked to reduced mortality
In patients receiving opioid substitution treatment for opioid use disorder (mainly involving heroin), those exhibiting a rapid decline in heroin use were found to be more likely to have successful treatment outcomes.
Electrical pulses are sent through small needles that are inserted in the ear to combat the early stages of detoxification, leading to stabilization.
Patients with migraine may exhibit higher prevalence of restless leg syndrome, fibromyalgia, and depressive symptoms compared with individuals not experiencing migraines.
Adding corticosteroids to epidural lidocaine injections does not improve patient-reported pain or function at 12 months.
The U.S. Food and Drug Administration has issued warnings to 9 online companies selling illegal opioid medications on 53 websites, in direct violation of the Federal Food, Drug, and Cosmetic Act.
Cryoablation also cuts the need for opioids at 24 hours post-treatment and at three months
Burden of deaths up; most patients receiving opioid analgesics use immediate-release formulations
Posttraumatic stress disorder symptoms may be associated with higher levels of acute pain and pain interference in low-income inner city women.
Lucemyra is an oral selective alpha 2-adrenergic receptor agonist